CREMOLINI, CHIARA Statistiche
CREMOLINI, CHIARA
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO).
2012-01-01 Salvatore, L; Masi, G; Loupakis, F; Cremolini, Chiara; Schirripa, M; Fornaro, L; Antoniotti, C; Vivaldi, C; Granetto, C; Fea, E; Antonuzzo, L; Giommoni, E; Boni, C; Banzi, M; Chiara, S; Sonaglio, C; Allegrini, G; Marcucci, L; Valsuani, C; Greco, F; Safina, V; Boni, L; Falcone, Alfredo
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
2015-01-01 Pietrantonio, Filippo; Aprile, Giuseppe; Rimassa, Lorenza; Franco, Pierfrancesco; Lonardi, Sara; Cremolini, Chiara; Biondani, Pamela; Sbicego, Elena Lara; Pasqualetti, Francesco; Tomasello, Gianluca; Niger, Monica; Casagrande, Mariaelena; Ghidini, Michele; Muni, Roberta; Montrone, Sabrina; Bergamo, Francesca; Berenato, Rosa; Fontanella, Caterina; Bozzarelli, Silvia; Moretto, Roberto; Battaglin, Francesca; Di Bartolomeo, Maria; De Braud, Filippo; Miceli, Rosalba
A perspective on the current management of advanced colorectal cancer
2013-01-01 Casagrande, Mariaelena; Cremolini, Chiara; Loupakis, Fotios; Aprile, Giuseppe
A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer
2020-01-01 Miyamoto, Y.; Schirripa, M.; Suenaga, M.; Cao, S.; Zhang, W.; Okazaki, S.; Berger, M. D.; Matsusaka, S.; Yang, D.; Ning, Y.; Baba, H.; Loupakis, F.; Lonardi, S.; Pietrantonio, F.; Borelli, B.; Cremolini, C.; Yamaguchi, T.; Lenz, H. -J.
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials
2020-01-01 Berger, M. D.; Ning, Y.; Stintzing, S.; Heinemann, V.; Cao, S.; Zhang, W.; Yang, D.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Hanna, D. L.; Soni, S.; Puccini, A.; Tokunaga, R.; Naseem, M.; Battaglin, F.; Cremolini, C.; Falcone, A.; Loupakis, F.; Lenz, H. -J.
A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab
2018-01-01 Berger, Martin D; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef
A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab
2018-01-01 Berger, Martin D; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef
A still missing piece of the FIRE-3 puzzle
2016-01-01 Antoniotti, Carlotta; Moretto, Roberto; Rossini, Daniele; Falcone, Alfredo; Cremolini, Chiara
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study
2019-01-01 Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M.
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.
2018-01-01 Cremolini, C; Antoniotti, Carlotta; Lonardi, S; Aprile, G; Bergamo, F; Masi, G; Grande, R; Tonini, G; Mescoli, C; Cardellino, Gg; Coltelli, L; Salvatore, Lisa; Corsi, Dc; Lupi, C; Gemma, D; Ronzoni, M; Dell'Aquila, E; Marmorino, F; Di Fabio, F; Mancini, Ml; Marcucci, L; Fontanini, G; Zagonel, V; Boni, L; Falcone, A
Advanced nanotechnology for enhancing immune checkpoint blockade therapy
2021-01-01 Cremolini, C.; Vitale, E.; Rastaldo, R.; Giachino, C.
ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer
2017-01-01 Pietrantonio, F; Di Nicolantonio, F; Schrock, Ab; Lee, J; Tejpar, S; Sartore Bianchi, A; Hechtman, Jf; Christiansen, J; Novara, L; Tebbutt, N; Fucà, G; Antoniotti, Carlotta; Kim, St; Murphy, D; Berenato, R; Morano, F; Sun, J; Min, B; Stephens, Pj; Chen, M; Cremolini, Chiara
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
2018-01-01 Pietrantonio, Filippo; Di Nicolantonio, Federica; Schrock, Alexa B; Lee, Jeeyun; Tejpar, Sabine; Sartore-Bianchi, Andrea; Hechtman, Jaclyn F; Christiansen, Jason; Novara, Luca; Tebbutt, Niall; Fucà, Giovanni; Antoniotti, Carlotta; Kim, Seung Tae; Murphy, Danielle; Berenato, Rosa; Morano, Federica; Sun, James; Min, Bosun; Stephens, Philip J; Chen, Marissa; Cremolini, Chiara
Amphiregulin (AR) expression in the prediction of benefit from cetuximab plus irinotecan in K-RAS wild-type metastatic colorectal cancer (mCRC) patients
2009-01-01 F., Loupakis; Cremolini, Chiara; G., Perrone; I., Stasi; L., Salvatore; B., Vincenzi; A., Ruzzo; M., Ronzoni; K., Bencardino; Falcone, Alfredo
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3
2019-01-01 Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha; Battaglin, Francesca; Lo, Jae Ho; Arai, Hiroyuki; Loupakis, Fotios; Stintzing, Sebastian; Puccini, Alberto; Berger, Martin D; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Salhia, Bodour; Mumenthaler, Shannon M; Weisenberger, Daniel J; Liang, Gangning; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; Millstein, Joshua; Lenz, Heinz-Josef
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
2012-01-01 Crea, F; Fornaro, L; Paolicchi, E; Masi, G; Frumento, P; Loupakis, F; Salvatore, L; Cremolini, C; Schirripa, M; Graziano, F; Ronzoni, M; Ricci, V; Farrar, Wl; Falcone, A; Danesi, R
AN EZH2 POLYMORPHISMS IS ASSOCIATED WITH CLINICAL OUTCOME IN METASTATIC COLORECTAL CANCER PATIENTS.
2012-01-01 Crea, F; Fornaro, L; Paolicchi, E; Masi, G; Frumento, P; Loupakis, F; Salvatore, L; Cremolini, Chiara; Schirripa, M; Graziano, F; Ronzoni, M; Ricci, V; Farrar, Wl; Falcone, Alfredo; Danesi, Romano
Analysis of NRAS mutation as poor prognostic indicator and predictor of resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in metastatic colorectal cancer (mCRC) patients (pts).
2013-01-01 Schirripa, M; Loupakis, F; Cremolini, Chiara; Morvillo, M; Bergamo, F; Zoratto, F; Salvatore, L; Antoniotii, C; Marmorino, F; Sensi, E; Lupi, C; Fontanini, Gabriella; DE GREGORIO, V; Giannini, R; Basolo, F; Masi, G; Falcone, Alfredo
Analysis of PTEN expression and KRAS mutations on primaries (PRIM) and metastases (METS) to predict benefit from cetuximab plus irinotecan (CETIRI) in metastatic colorectal cancer (MCRC) patients (PTS)
2008-01-01 Loupakis, F.; Pollina, L.; Ruzzo, A.; Masi, G.; Cremolini, Chiara; Scartozzi, M.; Floriani, I.; Santini, D.; Cascinu, S.; Falcone, Alfredo
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
2020-01-01 Dell'Aquila, E.; Zeppola, T.; Stellato, M.; Pantano, F.; Scartozzi, M.; Madaudo, C.; Pietrantonio, F.; Cremolini, C.; Aprile, G.; Vincenzi, B.; Moretto, R.; Puzzoni, M.; Garattini, S. K.; Lobefaro, R.; Tonini, G.; Santini, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO). | 1-gen-2012 | Salvatore, L; Masi, G; Loupakis, F; Cremolini, Chiara; Schirripa, M; Fornaro, L; Antoniotti, C; Vivaldi, C; Granetto, C; Fea, E; Antonuzzo, L; Giommoni, E; Boni, C; Banzi, M; Chiara, S; Sonaglio, C; Allegrini, G; Marcucci, L; Valsuani, C; Greco, F; Safina, V; Boni, L; Falcone, Alfredo | |
| A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer | 1-gen-2015 | Pietrantonio, Filippo; Aprile, Giuseppe; Rimassa, Lorenza; Franco, Pierfrancesco; Lonardi, Sara; Cremolini, Chiara; Biondani, Pamela; Sbicego, Elena Lara; Pasqualetti, Francesco; Tomasello, Gianluca; Niger, Monica; Casagrande, Mariaelena; Ghidini, Michele; Muni, Roberta; Montrone, Sabrina; Bergamo, Francesca; Berenato, Rosa; Fontanella, Caterina; Bozzarelli, Silvia; Moretto, Roberto; Battaglin, Francesca; Di Bartolomeo, Maria; De Braud, Filippo; Miceli, Rosalba | |
| A perspective on the current management of advanced colorectal cancer | 1-gen-2013 | Casagrande, Mariaelena; Cremolini, Chiara; Loupakis, Fotios; Aprile, Giuseppe | |
| A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer | 1-gen-2020 | Miyamoto, Y.; Schirripa, M.; Suenaga, M.; Cao, S.; Zhang, W.; Okazaki, S.; Berger, M. D.; Matsusaka, S.; Yang, D.; Ning, Y.; Baba, H.; Loupakis, F.; Lonardi, S.; Pietrantonio, F.; Borelli, B.; Cremolini, C.; Yamaguchi, T.; Lenz, H. -J. | |
| A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials | 1-gen-2020 | Berger, M. D.; Ning, Y.; Stintzing, S.; Heinemann, V.; Cao, S.; Zhang, W.; Yang, D.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Hanna, D. L.; Soni, S.; Puccini, A.; Tokunaga, R.; Naseem, M.; Battaglin, F.; Cremolini, C.; Falcone, A.; Loupakis, F.; Lenz, H. -J. | |
| A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab | 1-gen-2018 | Berger, Martin D; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef | |
| A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab or FOLFIRI/cetuximab | 1-gen-2018 | Berger, Martin D; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef | |
| A still missing piece of the FIRE-3 puzzle | 1-gen-2016 | Antoniotti, Carlotta; Moretto, Roberto; Rossini, Daniele; Falcone, Alfredo; Cremolini, Chiara | |
| A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study | 1-gen-2019 | Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M.; De Luca, E.; Rimassa, L.; Formica, V.; Leone, F.; Calvetti, L.; Aprile, G.; Antonuzzo, L.; Urbano, F.; Prenen, H.; Negri, F.; Di Donato, S.; Buonandi, P.; Tomasello, G.; Avallone, A.; Zustovich, F.; Moretto, R.; Antoniotti, C.; Salvatore, L.; Calegari, M. A.; Siena, S.; Morano, F.; Ongaro, E.; Cascinu, S.; Santini, D.; Ziranu, P.; Schirripa, M.; Buggin, F.; Prete, A. A.; Depetris, I.; Biason, P.; Lonardi, S.; Zagonel, V.; Fassan, M.; Di Maio, M. | |
| Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial. | 1-gen-2018 | Cremolini, C; Antoniotti, Carlotta; Lonardi, S; Aprile, G; Bergamo, F; Masi, G; Grande, R; Tonini, G; Mescoli, C; Cardellino, Gg; Coltelli, L; Salvatore, Lisa; Corsi, Dc; Lupi, C; Gemma, D; Ronzoni, M; Dell'Aquila, E; Marmorino, F; Di Fabio, F; Mancini, Ml; Marcucci, L; Fontanini, G; Zagonel, V; Boni, L; Falcone, A | |
| Advanced nanotechnology for enhancing immune checkpoint blockade therapy | 1-gen-2021 | Cremolini, C.; Vitale, E.; Rastaldo, R.; Giachino, C. | |
| ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer | 1-gen-2017 | Pietrantonio, F; Di Nicolantonio, F; Schrock, Ab; Lee, J; Tejpar, S; Sartore Bianchi, A; Hechtman, Jf; Christiansen, J; Novara, L; Tebbutt, N; Fucà, G; Antoniotti, Carlotta; Kim, St; Murphy, D; Berenato, R; Morano, F; Sun, J; Min, B; Stephens, Pj; Chen, M; Cremolini, Chiara | |
| ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer | 1-gen-2018 | Pietrantonio, Filippo; Di Nicolantonio, Federica; Schrock, Alexa B; Lee, Jeeyun; Tejpar, Sabine; Sartore-Bianchi, Andrea; Hechtman, Jaclyn F; Christiansen, Jason; Novara, Luca; Tebbutt, Niall; Fucà, Giovanni; Antoniotti, Carlotta; Kim, Seung Tae; Murphy, Danielle; Berenato, Rosa; Morano, Federica; Sun, James; Min, Bosun; Stephens, Philip J; Chen, Marissa; Cremolini, Chiara | |
| Amphiregulin (AR) expression in the prediction of benefit from cetuximab plus irinotecan in K-RAS wild-type metastatic colorectal cancer (mCRC) patients | 1-gen-2009 | F., Loupakis; Cremolini, Chiara; G., Perrone; I., Stasi; L., Salvatore; B., Vincenzi; A., Ruzzo; M., Ronzoni; K., Bencardino; Falcone, Alfredo | |
| AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3 | 1-gen-2019 | Tokunaga, Ryuma; Cao, Shu; Naseem, Madiha; Battaglin, Francesca; Lo, Jae Ho; Arai, Hiroyuki; Loupakis, Fotios; Stintzing, Sebastian; Puccini, Alberto; Berger, Martin D; Soni, Shivani; Zhang, Wu; Mancao, Christoph; Salhia, Bodour; Mumenthaler, Shannon M; Weisenberger, Daniel J; Liang, Gangning; Cremolini, Chiara; Heinemann, Volker; Falcone, Alfredo; Millstein, Joshua; Lenz, Heinz-Josef | |
| An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients | 1-gen-2012 | Crea, F; Fornaro, L; Paolicchi, E; Masi, G; Frumento, P; Loupakis, F; Salvatore, L; Cremolini, C; Schirripa, M; Graziano, F; Ronzoni, M; Ricci, V; Farrar, Wl; Falcone, A; Danesi, R | |
| AN EZH2 POLYMORPHISMS IS ASSOCIATED WITH CLINICAL OUTCOME IN METASTATIC COLORECTAL CANCER PATIENTS. | 1-gen-2012 | Crea, F; Fornaro, L; Paolicchi, E; Masi, G; Frumento, P; Loupakis, F; Salvatore, L; Cremolini, Chiara; Schirripa, M; Graziano, F; Ronzoni, M; Ricci, V; Farrar, Wl; Falcone, Alfredo; Danesi, Romano | |
| Analysis of NRAS mutation as poor prognostic indicator and predictor of resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in metastatic colorectal cancer (mCRC) patients (pts). | 1-gen-2013 | Schirripa, M; Loupakis, F; Cremolini, Chiara; Morvillo, M; Bergamo, F; Zoratto, F; Salvatore, L; Antoniotii, C; Marmorino, F; Sensi, E; Lupi, C; Fontanini, Gabriella; DE GREGORIO, V; Giannini, R; Basolo, F; Masi, G; Falcone, Alfredo | |
| Analysis of PTEN expression and KRAS mutations on primaries (PRIM) and metastases (METS) to predict benefit from cetuximab plus irinotecan (CETIRI) in metastatic colorectal cancer (MCRC) patients (PTS) | 1-gen-2008 | Loupakis, F.; Pollina, L.; Ruzzo, A.; Masi, G.; Cremolini, Chiara; Scartozzi, M.; Floriani, I.; Santini, D.; Cascinu, S.; Falcone, Alfredo | |
| Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? | 1-gen-2020 | Dell'Aquila, E.; Zeppola, T.; Stellato, M.; Pantano, F.; Scartozzi, M.; Madaudo, C.; Pietrantonio, F.; Cremolini, C.; Aprile, G.; Vincenzi, B.; Moretto, R.; Puzzoni, M.; Garattini, S. K.; Lobefaro, R.; Tonini, G.; Santini, D. |